Q2 Earnings Estimate for IMAX Issued By Wedbush (NYSE:IMAX)

IMAX Corporation (NYSE:IMAX) – Investment analysts at Wedbush raised their Q2 2025 earnings estimates for IMAX in a research report issued to clients and investors on Friday, July 11th. Wedbush analyst A. Reese now expects that the company will earn $0.11 per share for the quarter, up from their prior estimate of $0.09. Wedbush currently has a “Outperform” rating on the stock. The consensus estimate for IMAX’s current full-year earnings is $0.91 per share. Wedbush also issued estimates for IMAX’s Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.38 EPS, FY2025 earnings at $0.78 EPS, Q2 2026 earnings at $0.17 EPS, Q3 2026 earnings at $0.33 EPS, Q4 2026 earnings at $0.41 EPS, FY2026 earnings at $1.04 EPS and FY2027 earnings at $1.34 EPS.

A number of other equities research analysts also recently weighed in on IMAX. Wells Fargo & Company cut their price target on shares of IMAX from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Rosenblatt Securities reissued a “buy” rating and issued a $35.00 price target on shares of IMAX in a report on Friday. Benchmark reissued a “buy” rating on shares of IMAX in a report on Wednesday. Roth Capital reissued a “buy” rating and issued a $36.00 price target on shares of IMAX in a report on Wednesday, July 9th. Finally, B. Riley reissued a “buy” rating and issued a $36.00 price target on shares of IMAX in a report on Friday, May 16th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, IMAX currently has a consensus rating of “Buy” and an average price target of $31.70.

IMAX Stock Up 2.7%

Shares of IMAX opened at $26.88 on Monday. The firm has a 50-day moving average price of $27.26 and a 200 day moving average price of $25.50. The firm has a market capitalization of $1.44 billion, a PE ratio of 57.19, a P/E/G ratio of 2.08 and a beta of 0.80. IMAX has a 52-week low of $16.87 and a 52-week high of $29.66.

IMAX (NYSE:IMAX) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.11 by $0.02. The business had revenue of $86.67 million during the quarter, compared to analyst estimates of $82.95 million. IMAX had a net margin of 6.98% and a return on equity of 7.79%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.15 earnings per share.

IMAX announced that its Board of Directors has initiated a stock repurchase program on Thursday, June 12th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 6.5% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Hedge Funds Weigh In On IMAX

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Neuberger Berman Group LLC grew its stake in shares of IMAX by 4.1% in the first quarter. Neuberger Berman Group LLC now owns 13,838 shares of the company’s stock worth $365,000 after acquiring an additional 542 shares during the last quarter. Mission Wealth Management LP grew its stake in shares of IMAX by 2.9% in the first quarter. Mission Wealth Management LP now owns 30,408 shares of the company’s stock worth $801,000 after acquiring an additional 845 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of IMAX by 3.4% in the fourth quarter. MetLife Investment Management LLC now owns 25,918 shares of the company’s stock worth $664,000 after acquiring an additional 848 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of IMAX by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,395 shares of the company’s stock worth $625,000 after acquiring an additional 905 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of IMAX by 1.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 104,510 shares of the company’s stock worth $2,754,000 after acquiring an additional 1,309 shares during the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.

About IMAX

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.